VI
AMED

Versor Investments’s Amedisys AMED Stock Holding History

Versor Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,868
Closed -$373K – 738
2024
Q3 		$373K Sell
3,868
-2,853
-42% -$278K 0.06% 519
2024
Q2 		$617K Buy
6,721
+1,279
+24% +$119K 0.11% 288
2024
Q1 		$502K Sell
5,442
-18,844
-78% -$1.77M 0.1% 330
2023
Q4 		$2.31M Sell
24,286
-16,222
-40% -$1.52M 0.47% 19
2023
Q3 		$3.78M Buy
40,508
+37,083
+1,083% +$3.43M 0.77% 15
2023
Q2 		$313K Buy
+3,425
New +$281K 0.05% 399
2019
Q3 		– Sell
-7,899
Closed -$959K – 286
2019
Q2 		$959K Buy
7,899
+1,700
+27% +$202K 0.06% 165
2019
Q1 		$764K Buy
6,199
+3,699
+148% +$464K 0.07% 137
2018
Q4 		$293K Buy
+2,500
New +$295K 0.07% 220

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Versor Investments's AMED Position: Q4 2024 in Review

Versor Investments sold out of Amedisys (AMED) in Q4 2024, closing a stake of 3,868 shares — an estimated $373K sold.

Versor Investments first reported a position in AMED in Q4 2018 and held it in 9 quarters. The position peaked at $3.78M in Q3 2023. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Versor Investments reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Versor Investments sold 3,868 Amedisys shares in Q4 2024, an estimated $373K.
  • Versor Investments first reported a position in Amedisys in Q4 2018 and held it in 9 quarters.
  • Versor Investments's Amedisys position peaked at $3.78M in Q3 2023.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Versor Investments's 13F filing for Q4 2024, filed 5 Feb 2025.